Endocrine disruptors deregulate pancreatic islet β-cell function, development of peripheral insulin resistance, insulin production, β-cell mass (compensatory hyperplasia/hypertrophy of β-cells) and impaired insulin output, insulin signaling, increasing β-cell apoptosis. This evidence concerns the gene INS and Insulin resistance.